About this Session
Several advances have been made in the commercialization of AI-based decision support software in recent years. Retrospective studies have shown AI’s high performance compared with that of breast radiologists in several clinical applications in breast cancer screening and diagnostics. According to these studies, different types of AI-based solutions have the potential to reduce the workload and recall rate in screening and/or improve breast cancer detection.
Now an important task is to gain clarity about the AI applications that have most potential in breast cancer screening and diagnostics. Our expert panel will shed light on the role of AI in the clinical routine. They will discuss the chances, challenges, and concerns that put the use of AI in mammography and tomosynthesis to the test. You are invited to actively participate in this lively discussion.
1. Discuss the role of AI in the clinical routine with experts
2. Gain clarity on the AI applications that have most potential in breast cancer screening and diagnostics
3. Assess the chances, challenges, and concerns that put the use of AI to the test
Cancer Care Day
ECR - March 1, 2023
At Siemens Healthineers, we are striving to create a world without the fear of cancer. As we address a variety of cancer types, we are re-thinking Breast Care Day in broader terms and have evolved it into a completely new and holistic Cancer Care Day format for ECR 2023.